Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance development
| Image |  |
|---|---|
| Description | scientific article published on 01 March 2019 |
| Author/s |
author: Jeremie Vitte |
| Publication date | March 1, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |